Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 17, 2016, Pages 4564-4569

  Sparrow, Janet R ^a  

^a Department of Medicine   (United States)

Author keywords

Age related macular degeneration; Bisretinoids; Photoreceptor cells; Retinal pigment epithelium; Vitamin A aldehyde adducts

Indexed keywords

RETINAL; RETINOID; RETINOL;

ADDUCTION; AGE RELATED MACULAR DEGENERATION; AGING; ATTENUATION; AVOIDANCE BEHAVIOR; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DIET; GENETIC RISK; GENETIC VARIABILITY; GENETIC VARIATION; HUMAN; LIFESTYLE MODIFICATION; LIGHT; LOW GLYCEMIC ANTIOXIDANT RICH DIET; META ANALYSIS (TOPIC); MOLECULARLY TARGETED THERAPY; MULTICENTER STUDY (TOPIC); PRECLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINAL PIGMENT EPITHELIUM; REVIEW; RISK FACTOR; SMOKING; ANIMAL; MACULAR DEGENERATION; METABOLISM;

ANIMALS; HUMANS; MACULAR DEGENERATION; MOLECULAR TARGETED THERAPY; RETINAL PIGMENT EPITHELIUM; RETINALDEHYDE; RISK FACTORS;

EID: 84964767237     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1600474113     Document Type: Review

References (78)

1. McLeod DS, et al. (2009) Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 50(10):4982-4991.
2. Hageman GS, et al. (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20(6):705-732.
3. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC (2005) The US twin study of age-related macular degeneration: Relative roles of genetic and environmental influences. Arch Ophthalmol 123(3):321-327.
4. Fritsche LG, et al. (2016) A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet 48(2):134-143.
5. Fritsche LG, et al. (2013) Seven new loci associated with age-related macular degeneration. Nat Genet 45(4):433-439.
6. Grassmann F, et al. (2015) Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration. PLoS One 10(5):e0126636.
7. Friedrich U, et al. (2015) Synonymous variants in HTRA1 implicated in AMD susceptibility impair its capacity to regulate TGF-? signaling. Hum Mol Genet 24(22): 6361-6373.
8. Wang G, et al. (2010) Analysis of the indel at the ARMS2 3'UTR in age-related macular degeneration. Hum Genet 127(5):595-602.
9. Fritsche LG, et al. (2014) Age-related macular degeneration: Genetics and biology coming together. Annu Rev Genomics Hum Genet 15:151-171.
10. Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS (2010) Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol 128(3):349-358.
11. Klein R, Klein BEK, Wong TY, Tomany SC, Cruickshanks KJ (2002) The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: The Beaver Dam eye study. Arch Ophthalmol 120(11):1551-1558.
12. Tomany SC, Cruickshanks KJ, Klein R, Klein BEK, Knudtson MD (2004) Sunlight and the 10-year incidence of age-related maculopathy: The Beaver Dam Eye Study. Arch Ophthalmol 122(5):750-757.
13. Seddon JM, et al.; Eye Disease Case-Control Study Group (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 272(18):1413-1420.
14. Chiu CJ, Klein R, Milton RC, Gensler G, Taylor A (2009) Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements Br J Ophthalmol 93(9):1241-1246.
15. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119(10):1417-1436.
16. Chew EY, et al.; Age-Related Eye Disease Study 2 (AREDS2) Research Group (2014) Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol 132(2):142-149.
17. Age-Related Eye Disease Study 2 Research Group (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 309(19):2005-2015.
18. Chew EY, Klein ML, Clemons TE, Agrón E, Abecasis GR (2015) Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: To test or not to test? Ophthalmology 122(1):212-215.
19. Holz FG, Schmitz-Valckenberg S, Fleckenstein M (2014) Recent developments in the treatment of age-related macular degeneration. J Clin Invest 124(4): 1430-1438.
20. Ben-Shabat S, et al. (2002) Biosynthetic studies of A2E, a major fluorophore of retinal pigment epithelial lipofuscin. J Biol Chem 277(9):7183-7190.
21. Delori FC, et al. (1995) In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 36(3): 718-729.
22. Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ (1989) Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci 30(8):1691-1699.
23. Wu Y, Yanase E, Feng X, Siegel MM, Sparrow JR (2010) Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration. Proc Natl Acad Sci USA 107(16):7275-7280.
24. Yoon KD, Yamamoto K, Ueda K, Zhou J, Sparrow JR (2012) A novel source of methylglyoxal and glyoxal in retina: Implications for age-related macular degeneration. PLoS One 7(7):e41309.
25. Weng J, et al. (1999) Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell 98(1):13-23.
26. Kim SR, et al. (2004) Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E. Proc Natl Acad Sci USA 101(32):11668-11672.
27. Radu RA, et al. (2011) Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration. J Biol Chem 286(21):18593-18601.
28. Zhou J, Ueda K, Zhao J, Sparrow JR (2015) Correlations between photodegradation of bisretinoid constituents of retina and dicarbonyl-Adduct deposition. J Biol Chem 290(45):27215-27227.
29. Maeda A, Maeda T, Golczak M, Palczewski K (2008) Retinopathy in mice induced by disrupted all-trans-retinal clearance. J Biol Chem 283(39):26684-26693.
30. Maeda A, Golczak M, Maeda T, Palczewski K (2009) Limited roles of Rdh8, Rdh12, and Abca4 in all-trans-retinal clearance in mouse retina. Invest Ophthalmol Vis Sci 50(11):5435-5443.
31. Wu L, Nagasaki T, Sparrow JR (2010) Photoreceptor cell degeneration in Abcr (-/-) mice. Adv Exp Med Biol 664:533-539.
32. Handa JT (2012) How does the macula protect itself from oxidative stress Mol Aspects Med 33(4):418-435.
33. Age-Related Eye Disease Study Research Group; SanGiovanni JP, et al. (2007) The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 125(5):671-679.
34. Age-Related Eye Disease Study Group; SanGiovanni JP, et al. (2007) The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol 125(9):1225-1232.
35. Evans JR, Lawrenson JG (2012) Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 11:CD000254.
36. Sobrin L, Seddon JM (2014) Nature and nurture-genes and environment-predict onset and progression of macular degeneration. Prog Retin Eye Res 40:1-15.
37. Sparrow JR, et al. (2003) A2E-epoxides damage DNA in retinal pigment epithelial cells. Vitamin E and other antioxidants inhibit A2E-epoxide formation. J Biol Chem 278(20):18207-18213.
38. Zhou J, Gao X, Cai B, Sparrow JR (2006) Indirect antioxidant protection against photooxidative processes initiated in retinal pigment epithelial cells by a lipofuscin pigment. Rejuvenation Res 9(2):256-263.
39. Jang YP, Zhou J, Nakanishi K, Sparrow JR (2005) Anthocyanins protect against A2E photooxidation and membrane permeabilization in retinal pigment epithelial cells. Photochem Photobiol 81(3):529-536.
40. Cruickshanks KJ, Klein R, Klein BEK (1993) Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 111(4):514-518.
41. Cruickshanks KJ, Klein R, Klein BEK, Nondahl DM (2001) Sunlight and the 5-year incidence of early age-related maculopathy: The Beaver Dam Eye Study. Arch Ophthalmol 119(2):246-250.
42. Klein BE, et al. (2014) Sunlight exposure, pigmentation, and incident age-related macular degeneration. Invest Ophthalmol Vis Sci 55(9):5855-5861.
43. Huang EJ, et al. (2014) Prevalence and risk factors for age-related macular degeneration in the elderly Chinese population in south-western Taiwan: The Puzih eye study. Eye (Lond) 28(6):705-714.
44. Schick T, et al. (2015) History of sunlight exposure is a risk factor for age-related macular degeneration [published online ahead of print October 5, 2015]. Retina, 10.1097/IAE.0000000000000756.
45. Fletcher AE, et al. (2008) Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol 126(10):1396-1403.
46. Sui GY, et al. (2013) Is sunlight exposure a risk factor for age-related macular degeneration? A systematic review and meta-Analysis. Br J Ophthalmol 97(4): 389-394.
47. Kawaguchi R, et al. (2007) A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 315(5813):820-825.
48. Mata NL, Vogel R (2010) Pharmacologic treatment of atrophic age-related macular degeneration. Curr Opin Ophthalmol 21(3):190-196.
49. Mata NL, et al. (2013) Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration. Retina 33(3):498-507.
50. Caruso RC, et al. (1998) Effects of fenretinide (4-HPR) on dark adaptation. Arch Ophthalmol 116(6):759-763.
51. Quadro L, Hamberger L, Colantuoni V, Gottesman ME, Blaner WS (2003) Understanding the physiological role of retinol-binding protein in vitamin A metabolism using transgenic and knockout mouse models. Mol Aspects Med 24(6):421-430.
52. Dobri N, et al. (2013) A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis. Invest Ophthalmol Vis Sci 54(1):85-95.
53. Cioffi CL, et al. (2015) Bicyclic [3.3.0]-octahydrocyclopenta[c]pyrrolo antagonists of retinol binding protein 4: Potential treatment of atrophic age-related macular degeneration and Stargardt disease. J Med Chem 58(15):5863-5888.
54. Ma L, Kaufman Y, Zhang J, Washington I (2011) C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease. J Biol Chem 286(10):7966-7974.
55. Kaufman Y, Ma L, Washington I (2011) Deuterium enrichment of vitamin A at the C20 position slows the formation of detrimental vitamin A dimers in wild-type rodents. J Biol Chem 286(10):7958-7965.
56. Radu RA, et al. (2008) Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation. Invest Ophthalmol Vis Sci 49(9):3821-3829.
57. Kiser PD, et al. (2015) Catalytic mechanism of a retinoid isomerase essential for vertebrate vision. Nat Chem Biol 11(6):409-415.
58. Golczak M, Kuksa V, Maeda T, Moise AR, Palczewski K (2005) Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle. Proc Natl Acad Sci USA 102(23):8162-8167.
59. Jin M, Li S, Moghrabi WN, Sun H, Travis GH (2005) Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell 122(3):449-459.
60. Zhang J, et al. (2015) Expansion of first-in-class drug candidates that sequester toxic all-trans-retinal and prevent light-induced retinal degeneration. Mol Pharmacol 87(3):477-491.
61. Bavik C, et al. (2015) Visual cycle modulation as an approach toward preservation of retinal integrity. PLoS One 10(5):e0124940.
62. Kubota R, et al. (2014) Phase 1, dose-ranging study of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in healthy volunteers. Retina 34(3): 603-609.
63. Dugel PU, et al. (2015) Phase ii, randomized, placebo-controlled, 90-day study of emixustat hydrochloride in geographic atrophy associated with dry age-related macular degeneration. Retina 35(6):1173-1183.
64. Maiti P, et al. (2006) Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation. Biochemistry 45(3):852-860.
65. Maeda A, et al. (2011) Primary amines protect against retinal degeneration in mouse models of retinopathies. Nat Chem Biol 8(2):170-178.
66. Wu Y, Zhou J, Fishkin N, Rittmann BE, Sparrow JR (2011) Enzymatic degradation of A2E, a retinal pigment epithelial lipofuscin bisretinoid. J Am Chem Soc 133(4): 849-857.
67. Brady RO (2006) Emerging strategies for the treatment of hereditary metabolic storage disorders. Rejuvenation Res 9(2):237-244.
68. Julien S, Schraermeyer U (2012) Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys. Neurobiol Aging 33(10):2390-2397.
69. Nociari MM, et al. (2014) Beta cyclodextrins bind, stabilize, and remove lipofuscin bisretinoids from retinal pigment epithelium. Proc Natl Acad Sci USA 111(14): E1402-E1408.
70. Boyer NP, et al. (2012) Lipofuscin and N-retinylidene-N-retinylethanolamine (A2E) accumulate in retinal pigment epithelium in absence of light exposure: Their origin is 11-cis-retinal. J Biol Chem 287(26):22276-22286.
71. Sparrow JR (2003) Therapy for macular degeneration: Insights from acne. Proc Natl Acad Sci USA 100(8):4353-4354.
72. Teussink MM, et al. (2015) The effect of light deprivation in patients with Stargardt disease. Am J Ophthalmol 159(5):964-972.
73. Kong J, et al. (2008) Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy. Gene Ther 15(19):1311-1320.
74. Allocca M, et al. (2008) Serotype-dependent packaging of large genes in adeno-Associated viral vectors results in effective gene delivery in mice. J Clin Invest 118(5):1955-1964.
75. Schwartz SD, et al. (2015) Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: Follow-up of two open-label phase 1/2 studies. Lancet 385(9967):509-516.
76. Grassmann F, Fauser S, Weber BH (2015) The genetics of age-related macular degeneration (AMD): Novel targets for designing treatment options Eur J Pharm Biopharm 95(Pt B):194-202.
77. Csaky KG, Richman EA, Ferris FL, 3rd (2008) Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci 49(2):479-489.
78. Greenberg JP, et al. (2013) Quantitative fundus autofluorescence in healthy eyes. Invest Ophthalmol Vis Sci 54(8):5684-5693.